Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/6/2019
SIETES contiene 92761 citas

 
 
 1 a 20 de 21 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Fanning L, Ilomäki J, Bell JS, Darzinš P. The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation. Eur J Clin Pharmacol 2017;73:1427-36. [Ref.ID 102129]
2.Enlace a cita original Cita con resumen
Mahtani KR, Heneghan C. Novel oral anticoagulants for atrial fibrillation. BMJ 2016;354:i5187. [Ref.ID 100782]
3.Tiene citas relacionadas Cita con resumen
Christopoulos C. Questions about the reliability of ROCKET-AF anticoagulation data. BMJ 2016;352:i1039. [Ref.ID 100063]
4. Cita con resumen
Cohen D. Rivaroxaban: can we trust the evidence?. BMJ 2016;352:i575. [Ref.ID 100048]
5.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
6.Tiene citas relacionadas Cita con resumen
Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breidthardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowtitz SD, Nessel CC, Fox KAA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF). Lancet 2015;385:2363-70. [Ref.ID 99291]
7.Tiene citas relacionadas Cita con resumen
Khan SS, Gheorghiade M. Digoxin use in atrial fibrillation: a critical reappraisal. Lancet 2015;385:2330-2. [Ref.ID 99288]
8.Tiene citas relacionadas Cita con resumen
Sarrazin MSV, Rose A. Safety of new oral anticoagulants. BMJ 2015;350:h1679. [Ref.ID 98980]
9.Tiene citas relacionadas Cita con resumen
Chang H-Y, Zhou M, Tang W, Alexander GC, Singh S. Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study. BMJ 2015;350:h1585. [Ref.ID 98979]
10.Tiene citas relacionadas Cita con resumen
Abraham NS, Singh S, Alexander GC, Heien H, Haas LR, Crown W, Shah ND. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ 2015;350:h1857. [Ref.ID 98978]
11. Cita con resumen
Mahaffey KW, Wojdyla D, Hankey GJ, White HD, Nessel CC, Piccini JP, Patel MR, Berkowitz SD, Becker RC, Halperin JL, Singer DE, Califf RM, Fox KAA, Breithardt G, Hacke W. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. Ann Intern Med 2013;158:861-8. [Ref.ID 95680]
12.
García-Bragado F. La medicina actual ante los anticoagulantes de nueva generación. Med Clin (Barc) 2012;138:438-40. [Ref.ID 92561]
13.Tiene citas relacionadas Cita con resumen
Patel MR, Fox KAA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. Author/editor response. N Engl J Med 2011;365:2335. [Ref.ID 91975]
14.Tiene citas relacionadas Cita con resumen
Pearson S, Troughton R, Richards AM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:2334-5. [Ref.ID 91974]
15.Tiene citas relacionadas Cita con resumen
Rosenstein R, Parra D. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:2334. [Ref.ID 91973]
16.Tiene citas relacionadas Cita con resumen
Rose A. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:2333-4. [Ref.ID 91972]
17.Tiene citas relacionadas Cita con resumen
Nessner A. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:2333. [Ref.ID 91971]
18. Cita con resumen
19. Cita con resumen
Fleming TR, Emerson SS. Evaluating rivaroxaban for nonvalvular atrial fibrillation - Regulatory considerations. N Engl J Med 2011;365:1557-9. [Ref.ID 91586]
20. Cita con resumen
del Zoppo GJ, Eliasziw M. New options in anticoagulation for atrial fibrillation. N Engl J Med 2011;365:952-3. [Ref.ID 90983]
Seleccionar todas
 
 1 a 20 de 21 siguiente >>